These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 26681121)

  • 41. Predictors of death and transplant in patients with a mechanical circulatory support device: a multi-institutional study.
    Holman WL; Kormos RL; Naftel DC; Miller MA; Pagani FD; Blume E; Cleeton T; Koenig SC; Edwards L; Kirklin JK
    J Heart Lung Transplant; 2009 Jan; 28(1):44-50. PubMed ID: 19134530
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The Heartmate Risk Score predicts morbidity and mortality in unselected left ventricular assist device recipients and risk stratifies INTERMACS class 1 patients.
    Adamo L; Nassif M; Tibrewala A; Novak E; Vader J; Silvestry SC; Itoh A; Ewald GA; Mann DL; LaRue SJ
    JACC Heart Fail; 2015 Apr; 3(4):283-90. PubMed ID: 25770410
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Major bleeding during HeartMate II support.
    Bunte MC; Blackstone EH; Thuita L; Fowler J; Joseph L; Ozaki A; Starling RC; Smedira NG; Mountis MM
    J Am Coll Cardiol; 2013 Dec; 62(23):2188-96. PubMed ID: 23994419
    [TBL] [Abstract][Full Text] [Related]  

  • 44. First experience with the Synergy Micro-Pump in patients in INTERMACS class 1-2 as a bridge to transplantation: pushing the limits?
    Sabashnikov A; Popov AF; Bowles CT; Weymann A; Mohite PN; Wahlers T; Wittwer T; Zych B; Garcia-Saez D; Patil NP; Fatullayev J; Amrani M; Banner NR; Seidler T; Unsoeld B; Bireta C; Schoendube FA; Simon AR
    Artif Organs; 2015 Feb; 39(2):118-25. PubMed ID: 24841499
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Continuous-flow devices and percutaneous site infections: clinical outcomes.
    Goldstein DJ; Naftel D; Holman W; Bellumkonda L; Pamboukian SV; Pagani FD; Kirklin J
    J Heart Lung Transplant; 2012 Nov; 31(11):1151-7. PubMed ID: 22766022
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Quantifying the impact from stroke during support with continuous flow ventricular assist devices: An STS INTERMACS analysis.
    Kirklin JK; Naftel DC; Myers SL; Pagani FD; Colombo PC
    J Heart Lung Transplant; 2020 Aug; 39(8):782-794. PubMed ID: 32376278
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Regional differences in use and outcomes of left ventricular assist devices: Insights from the Interagency Registry for Mechanically Assisted Circulatory Support Registry.
    Krim SR; Vivo RP; Campbell P; Estep JD; Fonarow GC; Naftel DC; Ventura HO
    J Heart Lung Transplant; 2015 Jul; 34(7):912-20. PubMed ID: 25824553
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Safety of reduced anti-thrombotic strategies in HeartMate II patients: A one-year analysis of the US-TRACE Study.
    Katz JN; Adamson RM; John R; Tatooles A; Sundareswaran K; Kallel F; Farrar DJ; Jorde UP;
    J Heart Lung Transplant; 2015 Dec; 34(12):1542-8. PubMed ID: 26277569
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Postoperative Outcomes of the Largest HeartMate-II Experience in Turkey.
    Ertugay S; Engin C; Nalbantgil S; Kocabaş S; Balcioglu O; Engin Y; Yagdi T; Ozbaran M
    Transplant Proc; 2015 Jun; 47(5):1499-502. PubMed ID: 26093751
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Low incidence of gastrointestinal bleeding and pump thrombosis in patients receiving the INCOR LVAD system in the long-term follow-up.
    Iacovoni A; Centofanti P; Attisani M; Verde A; Terzi A; Senni M; Maiani M; Baronetto A; Livi U; Frigerio M; Rinaldi M
    Int J Artif Organs; 2015 Oct; 38(10):542-7. PubMed ID: 26541278
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Correlation of Pre-Explant Lactate Dehydrogenase Concentrations and Findings During Post-Explant Pump Analysis of the HeartMate II Left Ventricular Assist Device.
    Sood V; Alam O; Tchantchaleishvili V; Pagani FD; Aaronson KD; Haft J; Joyce DL; Joyce LD; Daly RC; Maltais S; Stulak JM
    Ann Thorac Surg; 2017 Apr; 103(4):1207-1213. PubMed ID: 27743635
    [TBL] [Abstract][Full Text] [Related]  

  • 52. HeartMate 3 in Lowest INTERMACS Profile Cohort: The Swiss Experience.
    Tozzi P; Banfi C; Ahmadov K; Hullin R; Meyer P; Giraud R; Liaudet L; Gronchi F; Huber C; Kirsch M
    ASAIO J; 2017; 63(6):752-758. PubMed ID: 28557861
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Hematologic markers better predict left ventricular assist device thrombosis than echocardiographic or pump parameters.
    Bartoli CR; Ghotra AS; Pachika AR; Birks EJ; McCants KC
    Thorac Cardiovasc Surg; 2014 Aug; 62(5):414-8. PubMed ID: 24995532
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Clinical Outcome and Comparison of Three Different Left Ventricular Assist Devices in a High-Risk Cohort.
    Zhigalov K; Mashhour A; Szczechowicz M; Mkalaluh S; Karagezian S; Gogia I; Isaev M; Kadyraliev BK; Easo J; Ennker J; Eichstaedt HC; Weymann A
    Artif Organs; 2018 Nov; 42(11):1035-1042. PubMed ID: 29774558
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The association of pretransplant HeartMate II left ventricular assist device placement and heart transplantation mortality.
    Donneyong M; Cheng A; Trivedi JR; Schumer E; McCants KC; Birks EJ; Slaughter MS
    ASAIO J; 2014; 60(3):294-9. PubMed ID: 24614355
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pre-implant left ventricular apex position predicts risk of HeartMate II pump thrombosis.
    Yarboro LT; Mehaffey JH; Hawkins RB; Kron IL; Ailawadi G; Kern JA; Ghanta RK
    J Card Surg; 2017 Dec; 32(12):837-842. PubMed ID: 29226531
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Age and gender differences and factors related to change in health-related quality of life from before to 6 months after left ventricular assist device implantation: Findings from Interagency Registry for Mechanically Assisted Circulatory Support.
    Grady KL; Sherri Wissman ; Naftel DC; Myers S; Gelijins A; Moskowitz A; Pagani FD; Young JB; Spertus JA; Kirklin JK
    J Heart Lung Transplant; 2016 Jun; 35(6):777-88. PubMed ID: 27068037
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Low Accuracy of the HeartMate Risk Score for Predicting Mortality Using the INTERMACS Registry Data.
    Kanwar MK; Lohmueller LC; Kormos RL; Loghmanpour NA; Benza RL; Mentz RJ; Bailey SH; Murali S; Antaki JF
    ASAIO J; 2017; 63(3):251-256. PubMed ID: 27984320
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Post-approval study of a highly pulsed, low-shear-rate, continuous-flow, left ventricular assist device, EVAHEART: a Japanese multicenter study using J-MACS.
    Saito S; Yamazaki K; Nishinaka T; Ichihara Y; Ono M; Kyo S; Nishimura T; Nakatani T; Toda K; Sawa Y; Tominaga R; Tanoue T; Saiki Y; Matsui Y; Takemura T; Niinami H; Matsumiya G;
    J Heart Lung Transplant; 2014 Jun; 33(6):599-608. PubMed ID: 24746637
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Temporal Differences in Outcomes During Long-Term Mechanical Circulatory Support.
    Maltais S; Anwer LA; Haglund NA; Cowger J; Shah P; Aaronson KD; Pagani FD; Dunlay SM; Singh R; Salerno CT; Stulak JM
    J Card Fail; 2017 Dec; 23(12):852-858. PubMed ID: 28757150
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.